U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07040566) titled 'A Randomized, Controlled Trial of Varenicline for E-cigarette Cessation' on June 18.
Brief Summary: This is randomized, placebo-controlled clinical trial in treatment-seeking adults who report regular e-cigarette use to test the hypothesis that varenicline is efficacious for quitting e-cigarettes.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
E-cigarette Use
Vaping
Nicotine Dependence
Intervention:
DRUG: Varenicline 1mg BID
12 weeks following the standard titration of 1 mg, twice daily
DRUG: Placebo
Matching placebo twice daily
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Yale University
Published...